Related Experiment Video

Updated: May 3, 2026

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
10:08

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain

Published on: August 28, 2012

11.4K

Bacterial and cell-free production of APP671-726 containing amyloid precursor protein transmembrane and metal-binding

O V Bocharova1, A S Urban, K D Nadezhdin

  • 1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia. o.bocharova@gmail.com.

Biochemistry. Biokhimiia
|January 28, 2014
PubMed

Insights

Researchers developed new methods to produce amyloid precursor protein (APP) fragments for Alzheimer's disease research. This facilitates structural studies crucial for understanding early disease mechanisms.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Structural Biology

Background:

  • Alzheimer's disease (AD) pathogenesis involves mutations in the amyloid precursor protein (APP) transmembrane domain.
  • These mutations are hypothesized to alter APP structure and dynamics, initiating disease.
  • The early molecular events in AD remain incompletely understood.

Purpose of the Study:

  • To investigate the molecular basis of Alzheimer's disease.
  • To produce a specific APP fragment (APP671-726) containing key functional domains for structural analysis.
  • To enable high-resolution structural studies of APP in membrane-mimicking environments.

Main Methods:

  • Development of a highly effective cell-free production method for APP671-726.
  • Improvement of bacterial synthesis methods for APP671-726.
  • Production of milligram quantities of isotope-labeled APP671-726.

Main Results:

  • Successful establishment of efficient cell-free and bacterial synthesis routes for APP671-726.
  • Generation of sufficient quantities of isotope-labeled protein for advanced structural studies.
  • Enabling high-resolution NMR spectroscopy of the APP fragment in membrane-mimicking environments.

Conclusions:

  • The developed production methods provide essential tools for studying APP structure and dynamics.
  • These advancements are critical for elucidating the initial molecular steps in Alzheimer's disease pathogenesis.
  • Facilitates future research into therapeutic strategies targeting APP processing.

More Related Videos

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

18.0K
Rapid Generation of Amyloid from Native Proteins In vitro05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

5.9K

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.2K
Amyloid Fibrils03:03

Amyloid Fibrils

5.2K
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94